Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxysteroid 17-beta-dehydrogenase 13 (HSD17B13) is a liver-enriched, hepatocyte-specific enzyme that localizes to the surface of lipid droplets. It belongs to the 17-beta-hydroxysteroid dehydrogenase family and is involved in the metabolism of lipids, steroids, and retinoids. Although its exact physiological substrates and molecular mechanisms remain incompletely understood, it is known to play a key role in hepatic lipid droplet biogenesis and lipid accumulation.
Human genetic studies have strongly validated HSD17B13 as a therapeutic target, showing that loss-of-function variants (such as rs72613567) provide significant protection against the progression of chronic liver diseases. This genetic protection spans metabolic dysfunction-associated steatohepatitis (MASH), alcoholic liver disease, cirrhosis, and hepatocellular carcinoma. Consequently, therapeutic strategies targeting HSD17B13 are under active clinical development to treat fibrotic liver diseases. These approaches include RNA interference (RNAi) therapeutics like rapirosiran and ARO-HSD, as well as oral small-molecule inhibitors like INI-822.
RNA interference (gene silencing) and small-molecule enzymatic inhibition
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxysteroid 17-beta-dehydrogenase 13 (HSD17B13).